The full results of the phase III REVERSE-IT trial continue to show that ticagrelor (Brilinta)-reversing therapy bentracimab ...
A BLA has been filed for bentracimab and, if approved, has the potential to be the first therapy to reverse the effects of ...
An investigational monoclonal antibody called bentracimab can safely and effectively reverse potentially catastrophic ...
A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's ...
Late-breaking data showed almost all patients achieved normal blood clotting and vessel repair after bentracimab infusion.
In a groundbreaking initiative, former President Donald Trump is poised to unveil a $150 trillion national 'endowment”, a move that could redefine the economic landscape of the United States. This ...
Annie Antar, MD, PhD, discusses the association between the symptoms of long COVID and HIV status. Annie Antar, MD, PhD, Johns Hopkins Medicine, spoke about how the likelihood of long COVID ...
A new review highlights the pivotal role of LSD1 (lysine-specific demethylase 1) in regulating critical cellular processes and its implications for human diseases. This article sheds light on how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback